Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock rose 42.9% to $2.3 during Monday’s pre-market session. The market value of their outstanding…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock increased by 42.2% to $2.29 during Friday’s pre-market session. The company’s market cap stands…
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machining.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Athenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday’s regular session. Trading volume for this…
Athenex Announces Quantum Leap Healthcare Collaborative Reports Trial Result Of I-SPY2 Trial For Oral Paclitaxel In Combination With PD-1 And Carboplatin In Neoadjuvant Breast Cancer
Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions announced that
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares moved upwards by 41.7% to $1.46 during Friday’s after-market session. The company’s…
Athenex Exits 503B Sterile Compounding Business
BUFFALO, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of